Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Technology Trust Regulatory News (PCT)

Share Price Information for Polar Capital Technology Trust (PCT)

Share Price is delayed by 15 minutes
Get Live Data
705.50    -23.00 (-3.16%)
Bid:
705.00
Ask:
706.00
Spread: 1.00 (0.142%)
Market Cap: £7.85b
PCT Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Technology Trust Share Chart

Annual Overview from QuotedData

16 Jan 2025 13:24

RNS Number : 6437T
Polar Capital Technology Trust PLC
16 January 2025
 

Polar Capital Technology - Annual Overview from QuotedData

16th January 2025

AI captain

Polar Capital Technology's (PCT's) manager contends that it has never been a better time to be an active manager in the artificial intelligence (AI) driven technology sector, with potential winners diversifying from the magnificent seven (Mag7) technology stocks (a group of seven major technology companies that have demonstrated significant influence and performance in financial markets, particularly in recent years - Apple, Microsoft, Aplhabet, Amazon, NVIDIA, Tesla and Meta Platforms) to a range of sectors and companies. Reflecting this, the fund's active share is as large at 50% as it has ever been, on the expectation that the spread in performance between large-cap and small- and mid-cap technology stocks will narrow considerably.

AI innovation, capex and adoption rates have all continued their rapid growth since our last note six months ago, which should act to quell fears of an AI-induced technology valuation bubble. The pace of corporate adoption has been particularly impressive, with several use-cases pointing to vast efficiency and productivity gains, suggesting a snowball in adoption. The skills of an active manager such as PCT's in picking AI winners (and identifying incumbent casualties) makes its 12.3% discount to net asset value (NAV) look good value.

Full Research:

https://quoteddata.com/research/polar-capital-technology-ai-captain-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Polar Capital Technology Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADFKFFLSEFA
Date   Source Headline
31st Mar 20261:19 pmRNSNet Asset Value(s)
30th Mar 202612:23 pmRNSNet Asset Value(s)
27th Mar 20261:03 pmRNSNet Asset Value(s)
26th Mar 202612:40 pmRNSNet Asset Value(s)
25th Mar 20261:19 pmRNSNet Asset Value(s)
24th Mar 20265:18 pmRNSTransaction in Own Shares
24th Mar 20261:18 pmRNSNet Asset Value(s)
23rd Mar 202612:52 pmRNSNet Asset Value(s)
20th Mar 20265:19 pmRNSTransaction in Own Shares
20th Mar 20261:42 pmRNSNet Asset Value(s)
19th Mar 20261:02 pmRNSNet Asset Value(s)
18th Mar 20265:16 pmRNSTransaction in Own Shares
18th Mar 20263:12 pmRNSDirector/PDMR Shareholding
18th Mar 202612:47 pmRNSNet Asset Value(s)
18th Mar 202612:20 pmRNSFactsheet
17th Mar 20265:30 pmRNSTransaction in Own Shares
17th Mar 20261:25 pmRNSNet Asset Value(s)
16th Mar 20261:40 pmRNSNet Asset Value(s)
16th Mar 202612:11 pmRNSDirector/PDMR Shareholding
9th Mar 20261:39 pmRNSNet Asset Value(s)
6th Mar 20261:27 pmRNSNet Asset Value(s)
5th Mar 202612:04 pmRNSNet Asset Value(s)
4th Mar 202612:51 pmRNSNet Asset Value(s)
3rd Mar 20264:30 pmRNSTop Ten Equity Holdings and Exposures
3rd Mar 202612:57 pmRNSNet Asset Value(s)
2nd Mar 20264:02 pmRNSTotal Voting Rights
2nd Mar 202612:16 pmRNSNet Asset Value(s)
27th Feb 202612:08 pmRNSNet Asset Value(s)
26th Feb 20264:18 pmRNS-RAnnual Overview from QuotedData
26th Feb 202612:00 pmRNSNet Asset Value(s)
25th Feb 202612:02 pmRNSNet Asset Value(s)
24th Feb 202612:01 pmRNSNet Asset Value(s)
23rd Feb 202611:14 amRNSNet Asset Value(s)
20th Feb 202611:57 amRNSNet Asset Value(s)
19th Feb 202612:01 pmRNSNet Asset Value(s)
18th Feb 202611:54 amRNSNet Asset Value(s)
18th Feb 202610:33 amRNSFactsheet
17th Feb 202612:05 pmRNSNet Asset Value(s)
16th Feb 202611:54 amRNSNet Asset Value(s)
13th Feb 20265:16 pmRNSTransaction in Own Shares
13th Feb 202612:41 pmRNSNet Asset Value(s)
12th Feb 202612:07 pmRNSNet Asset Value(s)
11th Feb 202612:28 pmRNSNet Asset Value(s)
10th Feb 202612:32 pmRNSNet Asset Value(s)
9th Feb 202612:08 pmRNSNet Asset Value(s)
6th Feb 20261:23 pmRNSNet Asset Value(s)
5th Feb 20265:19 pmRNSTransaction in Own Shares
5th Feb 202612:48 pmRNSNet Asset Value(s)
4th Feb 20265:20 pmRNSTransaction in Own Shares
4th Feb 202611:43 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.